A 6-year-old boy with bronchial asthma takes the beta-adrenergic agonist agent albuterol. The child's mother tells the nurse that she uses this medication to open her son's airway when he is having trouble breathing. What is the nurse's best response?

A. Advising the mother that overuse of albuterol may cause chronic bronchitis is not accurate. Chronic bronchitis is a long-term condition primarily related to smoking or other irritants and is not typically associated with the appropriate use of albuterol as a bronchodilator. B. Assuring the mother that she is using the medication correctly is not the best response, as it does not address the need for asthma management and education on the proper use of medications and when to seek medical attention. C. Recommending that the mother bring the child in for immediate evaluation is not necessary if the child's asthma symptoms are being effectively managed with albuterol. However, the child should have an asthma action plan and regular follow-up with a healthcare provider for asthma management. D Confirm that the medication helps to reduce airway inflammation. Albuterol is a beta-adrenergic agonist bronchodilator commonly used in the treatment of asthma. It helps to open the airways by relaxing the smooth muscles in the bronchi, making it easier for the child to breathe during an asthma attack. Albuterol does not treat airway inflammation, but it is used to provide quick relief from bronchoconstriction. The primary role of albuterol is to provide quick relief from acute bronchoconstriction during an asthma attack. It is not a medication for reducing airway inflammation, but it can be used in conjunction with other asthma medications that address inflammation, as prescribed by a healthcare provider. The nurse should educate the mother on the appropriate use of albuterol and the importance of asthma management under the guidance of a healthcare provider.